Cancer Family
Epithelial Neoplasm
CI-CAN-00000016Explore in graph →
Non-malignant7,525 active trials118 approved drugs1,152 evidence items
- NCIt
- C3709
Loading cancer entity…
Cancer Family
CI-CAN-00000016Explore in graph →
Clinical trials
26,878 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00380718 | Chemotherapy for Patients With Non-Small Cell Lung Cancer | completed | Phase 4 | 33 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 16, 2010 | clinicaltrials |
| NCT01082302 | Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage | completed | Phase 4 | 43 | MediGeneINDUSTRY | 1 | Sep 8, 2010 | clinicaltrials |
| NCT01000740 |
| A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa |
| completed |
| Phase 4 |
| 59 |
| AstraZenecaINDUSTRY |
| 1 |
| May 21, 2010 |
| clinicaltrials |
| NCT00733109 | Management of Cervical Intraepithelial Neoplasia Grade 2(CIN2) | completed | Phase 4 | 90 | Universidade Cidade de Sao PauloOTHER | 1 | Jan 11, 2010 | clinicaltrials |
| NCT00099541 | Non-small Cell Lung Cancer Registry | completed | Phase 4 | 300 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00115206 | Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy | completed | Phase 4 | — | AmgenINDUSTRY | 0 | Apr 6, 2009 | clinicaltrials |
| NCT00168987 | Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors | completed | Phase 4 | 30 | Charite University, Berlin, GermanyOTHER | 1 | May 9, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Nov 16, 2010source: clinicaltrials